Janux Therapeutics (JANX) Revenue (2021 - 2025)
Historic Revenue for Janux Therapeutics (JANX) over the last 5 years, with Q3 2025 value amounting to $10.0 million.
- Janux Therapeutics' Revenue rose 217790.43% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year decrease of 2336.58%. This contributed to the annual value of $10.6 million for FY2024, which is 3099.1% up from last year.
- Per Janux Therapeutics' latest filing, its Revenue stood at $10.0 million for Q3 2025, which was up 217790.43% from $439000.0 recorded in Q3 2024.
- In the past 5 years, Janux Therapeutics' Revenue ranged from a high of $10.0 million in Q3 2025 and a low of $380000.0 during Q1 2021
- For the 5-year period, Janux Therapeutics' Revenue averaged around $2.6 million, with its median value being $1.7 million (2021).
- Per our database at Business Quant, Janux Therapeutics' Revenue plummeted by 8255.86% in 2024 and then soared by 217790.43% in 2025.
- Janux Therapeutics' Revenue (Quarter) stood at $1.6 million in 2021, then surged by 76.05% to $2.8 million in 2022, then decreased by 13.5% to $2.5 million in 2023, then tumbled by 82.16% to $439000.0 in 2024, then soared by 2177.9% to $10.0 million in 2025.
- Its Revenue stands at $10.0 million for Q3 2025, versus $439000.0 for Q3 2024 and $8.9 million for Q2 2024.